This process results in improved energy and creates a more active cellular environment
"The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration." J Appl Physiol
Tendon & Tissue Recovery: The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration (Journal of Applied Physiology) Wound Healing Pathways: Stable Gastric Pentadecapeptide BPC 157 and Wound Healing (Frontiers in Pharmacology) Angiogenesis (BPC-157): Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation (PubMed) Actin Sequestration (TB-500): Structural basis of actin sequestration by thymosin-4 (PMC / NIH) Inflammation Modulation: Thymosin beta 4: A novel corneal wound healing and anti-inflammatory agent (PMC / NIH) Vascular Growth Factors: Thymosin 4 induces the expression of vascular endothelial growth factor (VEGF) (PubMed) Product Name: Wolverine Blend (BPC-157 + TB-500) Molecular Formula: BPC-157: CHNO TB-500: CHNOS Molecular Weight: BPC-157: 1419.55 g/mol TB-500: 4963.44 g/mol Amino Acid Sequence: BPC-157: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val TB-500: Ac-Ser-Asp-Lys-Pro-[43 amino acids total] Form: Lyophilized (freeze-dried) powder Purity: 98% (HPLC verified) Appearance: White to off-white powder Quantity per Vial: 20 mg total (10 mg BPC-157 + 10 mg TB-500)
WO 93/24521 and WO 94/11394 disclose BPC peptides which have organo-protective activity of the same type as known from the parent protein BPC
Saline is not the documented solvent for research peptides when "saline" appears in a peptide context, it's typically a labeling mistake on the supply side
Breaking down the numbers Your 80mg KLOW vial contains 50mg GHK-Cu, 10mg BPC-157, 10mg TB-500, and 10mg KPV
